RadNet Stock Forecast
NASDAQ: RDNTHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
RDNT analyst consensus
Consensus (7 analysts)
strong_buy
Avg. price target
$97.00+39.15%
- Strong buy 2
- Buy 5
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 7 Wall Street analysts covering RadNet (2026-11-17), 7 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $97.00, with a high estimate of $108.00 and a low estimate of $83.00. The average target implies upside of 39.1% from the current price of $69.71.
The spread between the highest and lowest targets is 30.1%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for RDNT.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 29% |
| Buy | 5 | 71% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-17.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $83.00 | +19.06% |
| Average target | $97.00 | +39.15% |
| High target | $108.00 | +54.93% |